Antiphospholipid Syndrome Risk Factors
Studies from University of Milan, Department of Internal Medicine add new findings in the area of antiphospholipid syndrome risk factors
Published in Blood Weekly, March 18th, 2010
Current study results from the report, 'Patients with antiphospholipid syndrome display endothelial perturbation,' have been published. According to a study from Italy, "There is strong evidence that antiphospholipid antibodies (aPL) perturb endothelium both in vitro and in experimental animal models. by inducing a vasculopathy and an endothelial pro-inflammatory/coagulant phenotype. However, few contrasting studies raised the issue about the possibility to detect a comparable endothelial perturbation in anti-phospholipid syndrome (APS) patients."
"The aim of this observational case-control study was to evaluate several parameters of endothelial perturbation in patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-03-18)
More Articles from Blood Weekly
- Baylor College of Medicine
Theory of single stem cell for blood components challenged - Emory University
Transplant drug preserves kidneys, avoids toxicity - Lifespan
Offering hope for tissue regeneration - University of Pittsburgh Schools of the Health Sciences
Kidney injury linked to greater risk of death among pneumonia patients - Children's Hospital Boston
Key Player Found for a Cancer Typical in Down Syndrome - Dexamethasone Therapy
Study results from Attikon University in the area of dexamethasone therapy published - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
